|By Marketwired .||
|February 14, 2014 04:45 PM EST||
COLUMBIA, MARYLAND and TORONTO, ONTARIO -- (Marketwired) -- 02/14/14 -- Medifocus Inc. (TSX VENTURE: MFS)(OTCQX: MDFZF) announced today a further extension of the final closing of its non-brokered private placement (the Offering) of $6,000,000 previously announced in August 2013. The Company previously disclosed the completion of the first tranche of the Offering, in an amount of $3,540,000, on December 18, 2013 and now expects to complete the Offering by February 28, 2014. All other terms and conditions of the Offering remain unchanged.
Medifocus owns two fully developed technology platforms with comprehensive United States and international patent protection: (i) The Endo-thermotherapy Platform-a catheter-basis focused heat technology platform that utilizes natural body openings to deliver precise microwave thermotherapy to the diseased sites. The United States Food and Drugs Administration (FDA) approved Prolieve Thermodilatation System for the treatment of Benign Prostatic Hyperplasia (BPH) was developed based on the Endo-thermotherapy and is currently generating revenue; and (ii) the Adaptive Phased Array (APA) Microwave Focusing Platform, invented by the Massachusetts Institute of Technology, licensed to Medifocus directs precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. Medifocus' APA 1000 Breast Cancer Treatment System, developed from the APA technology platform, has received approval from the FDA and Health Canada to conduct the pivotal Phase III clinical trials. Medifocus believes that these two technology platforms can provide the design basis for the development of multiple cancer treatment systems for surface, subsurface and deep seated localized and regional cancers. Please visit www.medifocusinc.com, www.prolieve.com and http://www.facebook.com/pages/Medifocus-Inc-Company-Page/546315028715627 for more details.
Forward-Looking Statements and Information
This news release contains "forward-looking statements" and "forward-looking information", which may not be based on historical facts. Forward-looking statements and forward-looking information, include, but are not limited to, information and statements with respect the structure and the proceeds of the Offering and the expected use of the proceeds. Forward-looking statements are frequently characterized by words such as "plan," "expect," "project," "intend," "believe," "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made. Such forward-looking statements and forward-looking information involve known and unknown risks, uncertainties and other factors that may cause the actual results events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements or forward-looking information. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements and forward-looking information. Except as required by applicable securities laws, Medifocus disclaims any obligation to update any such factors or to publicly announce the results of any revisions to any of the forward-looking statements or forward-looking information contained herein to reflect future results, events or developments.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Oct. 1, 2016 03:00 AM EDT Reads: 2,433
Oct. 1, 2016 03:00 AM EDT Reads: 1,964
Oct. 1, 2016 02:30 AM EDT Reads: 2,714
Oct. 1, 2016 02:30 AM EDT Reads: 648
Oct. 1, 2016 02:30 AM EDT Reads: 523
Oct. 1, 2016 02:30 AM EDT Reads: 3,026
Oct. 1, 2016 02:15 AM EDT Reads: 5,457
Oct. 1, 2016 02:15 AM EDT Reads: 2,123
Oct. 1, 2016 02:15 AM EDT Reads: 516
Oct. 1, 2016 02:15 AM EDT Reads: 757
Oct. 1, 2016 01:45 AM EDT Reads: 510
Oct. 1, 2016 01:15 AM EDT Reads: 721
Oct. 1, 2016 01:15 AM EDT Reads: 3,045
Oct. 1, 2016 12:15 AM EDT Reads: 1,428
In this strange new world where more and more power is drawn from business technology, companies are effectively straddling two paths on the road to innovation and transformation into digital enterprises. The first path is the heritage trail – with “legacy” technology forming the background. Here, extant technologies are transformed by core IT teams to provide more API-driven approaches. Legacy systems can restrict companies that are transitioning into digital enterprises. To truly become a lea...
Sep. 30, 2016 11:30 PM EDT Reads: 774